A detailed history of Natixis Advisors, L.P. transactions in Globus Medical Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 259,512 shares of GMED stock, worth $18.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
259,512
Previous 230,874 12.4%
Holding current value
$18.3 Million
Previous $12.4 Million 43.52%
% of portfolio
0.04%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$49.79 - $68.85 $1.43 Million - $1.97 Million
28,638 Added 12.4%
259,512 $17.8 Million
Q1 2024

Apr 25, 2024

BUY
$51.15 - $56.52 $4.13 Million - $4.56 Million
80,760 Added 53.8%
230,874 $12.4 Million
Q4 2023

Feb 06, 2024

BUY
$43.79 - $55.14 $2.06 Million - $2.59 Million
47,047 Added 45.65%
150,114 $8 Million
Q3 2023

Nov 13, 2023

BUY
$49.1 - $62.37 $3.91 Million - $4.97 Million
79,698 Added 341.04%
103,067 $5.12 Million
Q2 2023

Aug 15, 2023

BUY
$52.61 - $59.54 $270,310 - $305,916
5,138 Added 28.18%
23,369 $1.39 Million
Q1 2023

May 11, 2023

SELL
$51.83 - $79.63 $744,589 - $1.14 Million
-14,366 Reduced 44.07%
18,231 $1.03 Million
Q4 2022

Jan 27, 2023

BUY
$58.4 - $75.53 $357,524 - $462,394
6,122 Added 23.12%
32,597 $2.42 Million
Q3 2022

Nov 14, 2022

SELL
$55.32 - $67.54 $4.04 Million - $4.93 Million
-73,039 Reduced 73.4%
26,475 $1.58 Million
Q2 2022

Aug 12, 2022

SELL
$53.08 - $81.37 $1.71 Million - $2.61 Million
-32,125 Reduced 24.4%
99,514 $5.59 Million
Q1 2022

May 12, 2022

BUY
$63.68 - $75.54 $3.27 Million - $3.88 Million
51,376 Added 64.01%
131,639 $9.71 Million
Q4 2021

Feb 08, 2022

SELL
$62.62 - $79.92 $3.31 Million - $4.22 Million
-52,861 Reduced 39.71%
80,263 $5.8 Million
Q3 2021

Nov 15, 2021

BUY
$76.41 - $84.06 $8.26 Million - $9.08 Million
108,073 Added 431.41%
133,124 $10.2 Million
Q2 2021

Aug 12, 2021

BUY
$61.85 - $77.53 $422,064 - $529,064
6,824 Added 37.44%
25,051 $1.94 Million
Q1 2021

May 05, 2021

SELL
$60.05 - $67.74 $26,121 - $29,466
-435 Reduced 2.33%
18,227 $1.12 Million
Q4 2020

Feb 12, 2021

SELL
$48.89 - $65.87 $35,836 - $48,282
-733 Reduced 3.78%
18,662 $1.22 Million
Q3 2020

Nov 12, 2020

BUY
$45.26 - $57.82 $877,817 - $1.12 Million
19,395 New
19,395 $960,000
Q2 2020

Aug 11, 2020

SELL
$39.81 - $55.61 $1.69 Million - $2.36 Million
-42,404 Closed
0 $0
Q1 2020

Apr 27, 2020

BUY
$35.06 - $59.45 $1.49 Million - $2.52 Million
42,404 New
42,404 $1.8 Million
Q2 2018

Aug 14, 2018

SELL
$47.96 - $57.41 $1.19 Million - $1.43 Million
-24,875 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$42.75 - $51.73 $1,111 - $1,344
26 Added 0.1%
24,875 $1.24 Million
Q4 2017

Feb 14, 2018

BUY
$28.86 - $41.64 $22,539 - $32,520
781 Added 3.24%
24,849 $1.02 Million
Q3 2017

Nov 14, 2017

BUY
$28.28 - $30.85 $680,643 - $742,497
24,068
24,068 $715,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.44B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.